Animal Health Archives
Animal Health
04/21/2026
Validated Shipping Systems are the Foundation of Risk-Mitigated Animal Health Logistics
Animal health logistics are entering a phase where variability is no longer tolerable. Vaccines, biologics, reproductive materials, and advanced therapies are sensitive to critical parameters like temperature and handling conditions, and as regulatory expectations continue to move toward tighter controls and clearer documentation, shipping has become so much more than a support function.
Animal Health
03/19/2026
The Visibility and Traceability Animal Health Programs Need
Temperature-sensitive materials now move through animal health programs in far greater volumes, and that shift has raised the bar for how their transit needs to be documented. Teams responsible for oversight want documentation that reflects actual handling conditions from origin to delivery, with enough detail to support a clear assessment of risk. While the regulatory environment for animal health lags behind that for human health, programs are increasingly expected to provide records that reflect the actual conditions and custody of the material throughout transit.
Animal Pharmaceuticals
09/16/2025
Temperature-Controlled Shipping: A Lifeline for Animal Health Companies
For animal health companies, the success of a product is determined long before it reaches the veterinary clinic, farm, or research facility. No matter how innovative a vaccine, biologic, or next-gen therapy may be, its ultimate impact depends on maintaining its integrity during transportation. Temperature-controlled logistics are no longer a back-office concern, they have become a core element of success that impacts product efficacy, regulatory compliance, and even operational efficiency.
Industry Insights
07/22/2025
What’s Next for the CGT Industry? Mid-Year Check-In from the Leadership Team
We’re halfway through 2025, and the cell and gene therapy (CGT) landscape stands at a crossroads. Innovation continues to advance, yet the infrastructure required to support commercialization remains under pressure. To assess the current state of the industry and what’s ahead, Cryoport Systems gathered candid insights from our internal leaders across functions, from product development and commercial strategy to operations and client engagement.
Managing the Cold Chain
06/28/2025
Celebrating Logistics, the Unsung Hero in Cell and Gene Therapy Innovation
Every National Logistics Day offers a chance to recognize the systems and people that quietly power the innovation engine for Cell and Gene Therapy (CGT). While logistics frequently brings to mind images of trucks and warehouses, cardboard boxes, and tracking numbers, for CGT developers, it’s the infrastructure that protects innovation and ensures that time-sensitive, potentially life-changing treatments reach patients intact and on time. At Cryoport Systems, logistics has never been just about transportation. It’s about Enabling the Outcome™.
Navigating Logistics
06/27/2025
Bridging the Gaps: How Cryoshuttle® Enhances First and Last Mile Resilience
For advanced therapies, the most vulnerable parts of the transportation journey aren’t always the longest. In fact, the greatest risks often occur in the shortest distances. While intercontinental transport and customs clearance are well-known hurdles, both the first and last mile remain highly vulnerable to disruption. Cryoport Systems developed our Cryoshuttle® local pickup and delivery services to help close the gap between global transport lanes and local handling environments.
Animal Pharmaceuticals
06/17/2025
Ensuring Safe, On-Time Deliveries for Animal Biopharma
Transporting advanced therapeutics for the animal health industry is just as time- and temperature-sensitive as human therapeutics, yet it is not often managed with the same level of care. This results in biologics and vaccines running into preventable risk during transit. Whether you’re supporting a clinical trial, delivering commercial supply, or responding to a health emergency, ensuring the quality, compliance, and visibility of every shipment is crucial.
Industry Insights
06/04/2025
Engineering for Impact: A Conversation with Mike Dybicz on the HV3 and Safepak Systems
When it comes to cell and gene therapy (CGT) logistics, innovation is about more than improving efficiency, it’s about safeguarding a patient’s only chance at treatment. We sat down with Mike Dybicz, Senior Vice President & Chief Product Development Officer, to discuss how Cryoport Systems is reshaping the future of CGT logistics with innovative products such as Cryoport Express® Cryogenic HV3 Shipping System and Safepak® System 1800, designed specifically to reduce risk, increase reliability, and ultimately improve patient outcomes.
Patient Access and Awareness
06/01/2025